Research Article
Exploring Mentorship as a Novel Approach to Improving Quality of Life in Sarcoma Survivors: A Qualitative Pilot Study
Table 1
Mentees’ demographic information and disease characteristics (N = 7).
| | Demographic and disease characteristics | No. |
| | Sex (male:female) | 2 : 5 | | Age1 | | 20–35 | 4 | | 36–50 | 2 | | 51–60 | 1 |
| | Marital status | | Married | 1 | | Cohabitant | 1 | | Single | 5 |
| | Parental status | | Children | 4 | | No children | 3 |
| | Employment status | | Student | 1 | | Full employment | 1 | | Partly employed/disability benefit | 4 | | Benefit recipient | 1 |
| | Time since finished treatment | | 2 years | 4 | | 4–5 years | 2 | | >10 years | 1 |
| | Type of sarcoma | | Ewing sarcoma | 2 | | GIST | 1 | | Chordoma | 1 | | Rhabdomyosarcoma | 1 | | MPNST | 1 | | Chondrosarcoma | 1 |
| | Treatment | | Surgery | 3 | | Surgery + chemotherapy | 1 | | Surgery + chemotherapy (including HMAS) | 2 | | Surgery + chemotherapy + radiotherapy | 1 |
|
|
1Age when enrolled in the mentorship program. HMAS = high-dose chemotherapy with stem-cell rescue; GIST = gastrointestinal stromal tumor; MPNST = malignant peripheral nerve sheath tumor.
|
